Published in:
Open Access 01-12-2020 | Upper and Lower Gastrointestinal Endoscopy | Case report
Gastropathy associated with lanthanum phosphate deposition that was endoscopically tracked for 3 years. A case report
Published in: BMC Gastroenterology | Issue 1/2020
Login to get accessAbstract
Background
With the recent increased use of lanthanum carbonate, several cases of lanthanum phosphate deposition to gastric mucosa in dialysis patients have been reported. However, the endoscopic appearance of the early-stage lesion and the over-time alterations of endoscopic findings due to the progression of lanthanum phosphate deposition remain unclear.
Case presentation
An 80-year-old man receiving dialysis and taking lanthanum carbonate as a phosphate binder over a 4-year period underwent upper gastrointestinal endoscopy four times beginning 1 year after initiation of treatment. The first endoscopic examination (after 1 year of exposure to lanthanum carbonate) revealed rough mucosa with a few areas of white granular mucosa. Over the 3 years of endoscopic follow-up, the white granular mucosa spread and multiple erosions appeared. Histopathological findings of biopsy specimens from an erosion showed extensive infiltration by histiocytes containing deposits. Scanning electron microscopy-energy dispersive X-ray spectroscopy (SEM-EDX) revealed that the presence of the deposits containing phosphorus and lanthanum in the gastric mucosa.
On the basis of these results, the patient was diagnosed with gastropathy associated with lanthanum phosphate deposition.
Conclusions
Over a 3-year period, endoscopic findings associated with lanthanum deposition gradually changed and expanded from the early stage.